NOVOPULMON NOVOLIZER 400 micrograms/dose, powder for inhalation 100 doses, CIP 3400936984615
Active ingredients: Budesonide
Commercialized according to BDPMDispensing in France: Prescription only
Powder for inhalation100 doses, CIP 3400936984615inhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NOVOPULMON NOVOLIZER 400 microgrammes/dose, poudre pour inhalation
- Pharmaceutical form
- poudre pour inhalation
- Route of administration
- inhalée
- Presentation description
- 1 cartouche(s) acrylonitrile butadiène styrène polypropylène de 100 dose(s) avec inhalateur(s)
- Marketing authorisation holder
- VIATRIS MEDICAL
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 17 May 2006
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67008036CIP73698461CIP133400936984615Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BUDÉSONIDEpoudre | 400 microgrammes · une dose mesurée | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.